Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients

Reyes-Madrigal, F., Guma, E., León-Ortiz, P., Gómez-Cruz, G., Mora-Durán, R., Graff-Guerrero, A., Kegeles, L. S., Chakravarty, M. M., & de la Fuente-Sandoval, C. (2022). Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 113, 110473. https://doi.org/10.1016/j.pnpbp.2021.110473
Authors:
Francisco Reyes-Madrigal
Elisa Guma
Pablo León-Ortiz
Gladys Gómez-Cruz
Ricardo Mora-Durán
Ariel Graff-Guerrero
Lawrence S. Kegeles
M. Mallar Chakravarty
Camilo de la Fuente-Sandoval
Affiliated Authors:
Lawrence S. Kegeles
Columbia Affiliation:
Subjects:
Corpus Striatum (MeSH)
Glutamic Acid (MeSH)
Psychotic Disorders (MeSH)
Risperidone (MeSH)
Schizophrenia, Treatment-Resistant (MeSH)
Serotonin Antagonists (MeSH)
Author Keywords:
first episode
schizophrenia
glutamate
magnetic resonance spectroscopy
brain volume analysis
antipsychotic treatment
elink
Publication Type:
Article
Unique ID:
10.1016/j.pnpbp.2021.110473
PMID:
34748864
DOI:
10.1016/j.pnpbp.2021.110473
Journal:
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record

Record Created: